J. William (Bill) McEvoy is Established Professor of Preventive Cardiology at University of Galway and a Consultant Cardiologist at University Hospital Galway, IRL. He also serves as Medical and Research Director of the National Institute for Prevention and Cardiovascular Health (NIPC, a target=_blank rel=nofollow href=https:www.nipc.iehttps:www.nipc.ie ). Prof. McEvoy is a 2004 first class honours graduate of UCC School of Medicine, Cork, IRL. He received the Intern of the Year award at Cork University Hospital in 2005. He then undertook senior house officer and cardiology registrar training at the Mater University Hospital in Dublin. In 2008, he joined the Osler Medical Housestaff at the Johns Hopkins Hospital and University School of Medicine in Baltimore, Maryland, USA. After internal medicine residency, he completed cardiology fellowship at Hopkins including advanced training in preventive cardiology, cardiac imaging, and cardiovascular epidemiology. He received the Johns Hopkins Department of Medicine teaching award for fellows in 2013. He was the inaugural Pollin Cardiovascular Disease Prevention Fellow under Prof. Roger Blumenthal in 2013 and also served as the Hopkins Chief Cardiology Fellow in 2014 under Prof. Steven Schulman. He holds Masters degrees in cardiovascular epidemiology from the Johns Hopkins Bloomberg School of Public - No restriction Health and in the education of health professionals from the Johns Hopkins School of Education. Prior to returning to Ireland in 2018, Prof. McEvoy was an Assistant Professor on the cardiology faculty at Johns Hopkins for 3 years, with clinical roles in the cardiac intensive care unit and in the Ciccarone primary and secondary cardiovascular disease prevention centre. Prof. McEvoys research focuses on clinical epidemiology and novel biomarkers of risk; with a particular emphasis on hypertension and atherosclerosis. His research has resulted in numerous peer-reviewed Public - No restrictionations, grants and awards. For example, hereceivedthe 2024 Viviane Conraads Outstanding Achievement award from the European Society of Cardiology (ESC) and European Association of Preventive Cardiology. Click ona target=_blank rel=nofollow href=https:www.ncbi.nlm.nih.govpubmed?term=mcevoy+jwhttps:www.ncbi.nlm.nih.govpubmed?term=mcevoy+jw for a full list of peer-reviewed indexed Public - No restrictionations. He holds a PhD in medicine for a thesis entitled, Phenotyping for a personalised approach to CVD prevention. He served on the writing committee for the 2019 AHAACC primary CVD prevention guideline. As an internationally recognized expert in hypertension, he co-chaired the 2024 ESC Guidelines on the management of elevated blood pressure and hypertension. He is a Fellow of the Royal College of Physicians of Ireland and has a clinical interest in the primary and secondary prevention of cardiovascular disease.

Prof. McEvoys research focuses on testing novel biomarkers of risk and clinical epidemiology; with an emphasis on hypertension and atherosclerosis. His research has resulted in numerous peer-reviewed Public - No restrictionations, grants and awards. a target=_blank rel=nofollow href=https:www.ncbi.nlm.nih.govpubmed?term=mcevoy+jwhttps:www.ncbi.nlm.nih.govpubmed?term=mcevoy+jw .